Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age‐related macular degeneration

Publisher： John Wiley & Sons Inc

E-ISSN： 1476-5381|171|15|3754-3763

ISSN： 0007-1188

Source： BRITISH JOURNAL OF PHARMACOLOGY (ELECTRONIC), Vol.171, Iss.15, 2014-08, pp. : 3754-3763

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of age‐related macular degeneration and therapeutic opportunities

By  

THE JOURNAL OF PATHOLOGY, Vol. 232, Iss. 2, 2014-01 ,pp. : 151-164

John Wiley & Sons Inc

Access to resources Recommend Favorite

What is new in the management of wet age-related macular degeneration?

By Sivaprasad Sobha   Hykin Philip  

British Medical Bulletin, Vol. 105, Iss. 1, 2013-03 ,pp. : 201-211

Oxford University Press

Access to resources Recommend Favorite

Recent advances in the treatment of age-related macular degeneration

By Solebo Ameenat Lola   Angunawela Romesh I   Dasgupta Samipa   Marshall John  

British Journal of General Practice, Vol. 58, Iss. 550, 2008-05 ,pp. : 309-310

Royal College of General Practitioners

Access to resources Recommend Favorite

Age-related macular degeneration: an overview and update

By Lip PL   Menon VJK  

Therapy, Vol. 3, Iss. 3, 2006-05 ,pp. : 417-424

Future Medicine

Access to resources Recommend Favorite

Photobiomodulation in dry age‐related macular degeneration

By  

ACTA OPHTHALMOLOGICA, Vol. 96, Iss. 1, 2018-02 ,pp. : e92-e92

John Wiley & Sons Inc

Access to resources Recommend Favorite